In univariate analysis, MS4A expression in tumor cells, age, WHO grade, IDH status, and 1p/19q codeleted status was shown to be prognostic variables for the prognosis of the overall survival in glioma patients. This evidence concerns the gene IDH1 and central nervous system cancer.